NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ('Aptorum Group” or 'Aptorum”), a clinical stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results